1955 Capital — Full Portfolio
15 tracked investments · listed companies and verified rows first
AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesNew York, US
Bernard Peperstraete(Co-Founder and CEO)in
Ampaire develops hybrid-electric propulsion systems for aircraft, with the AmpDrive technology deployed across multiple aircraft types to reduce fuel consumption, maintenance costs, and noise emissions.
CleantechClimate TechEnergyHardwareSpace TechLos Angeles, US
Kevin Noertker(Executive Officer, Director)inCory Combs(Executive Officer, Director)inRyan Bilton(Executive Officer, Director)
Co-investorsAutodesk FoundationHemisphere Ventures LLCSand Hill AngelsTechstarsMassive
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
AI & Machine LearningBiotechHealthtechMedical DevicesTokyo, JP
Ryuichi Onose(Executive Officer, Director)inYuki Ichikawa(Director)Mika Yui(Director)
Co-investorsGlobal BrainAozora Corporate InvestmentDreamers VC
.png){kind=logo}
Crop Enhancement develops CropCoat, a nontoxic crop treatment that leaves no residue on the harvested crop, aimed at agricultural growers.
AgTechNew Materials
Co-investorsBandgap VenturesPhoenix Venture PartnersSpruce Capital Partners
Combining cost & safety of lead-acid and performance & lifetime of Li-ion
Santa Clara, US
Christiaan W Beekhuis(Executive Officer, Director)
BoardDan Miller(Director)Roger Strauch(Director)inMichele Klein(Director)Ray Kubis(Director)
Co-investorsAugust CapitalThe Roda Group
The Fynder Group develops a biotechnology platform using extremophile fungi to produce specialty ingredients, biopharmaceutical drugs, and bio-based materials for food, beverage, pharmaceutical, and textile applications.
BiotechFoodTechNew MaterialsChicago, US
Matthew Strongin(Founder)in
Co-investorsBreakthrough Energy VenturesDanone Manifesto VentureLauder PartnersSoftBank Vision Fund
Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Jian Zhang(Founder & CEO)Enrique RomoinFrank Grilloin
Co-investorsChina Growth CapitalLYFE CapitalProsperity7 VenturesShangBay Capital LLC
<UNKNOWN>
San Francisco, US
Bastian Lehman(Founder & CEO)Sam Street(Founder)inSean Plaice(Director)inBastian Lehmann(Executive Officer, Director)
BoardLee Fixel(Director)Scott Banister(Director)in
Co-investorsAngelPadBrighter CapitalCrosslink CapitalEntrée CapitalExpansion Venture CapitalFirstMark Capital+31 more
VitalBio develops the VitalOne, a diagnostic device that delivers comprehensive lab-grade blood test results in minutes from a small blood sample, using robotics, biochemistry, computer vision, and microfluidics.
BiotechDigital HealthMedical Devices
Vasu Nadella(Founder)in
Co-investorsNext VenturesInovia CapitalLachy GroomMarc BenioffNorthpond VenturesSam Altman+6 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Novel MaterialsOmnivoreSustainable BioproductsSustainable manufacturingSustainable transportationWaste-to-Value Chemicals
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.